Clinical Trials Directory

Trials / Completed

CompletedNCT04907565

Impact of Obesity on Post-operative Cognitive Dysfunction: Role of Adipose Tissue

Status
Completed
Phase
Study type
Observational
Enrollment
115 (actual)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
60 Years – 99 Years
Healthy volunteers
Not accepted

Summary

This research aims at describing the relationship between white adipose tissue inflammation and post-operative cognitive dysfunctions.The possible link between inflammatory cytokines secretions of the white adipose tissue of a surgical wound and the arising of patient's cognitive dysfunction in the post-operative course will be investigated. The hypothesis is that obese patient's inflammation of the white adipose tissue leads to cognitive dysfunction.

Detailed description

The postoperative cognitive dysfunctions (POCD) are characterized by delirium and cognitive impairment. The delirium is defined by an acute altered attention with a fluctuating course. The post-operative cognitive impairment involves the early alteration of different functions including memory, attention and cognitive flexibility. POCD have a major impact in patient's morbidity. They are linked to the systemic inflammation induced by the surgical wound. The systemic inflammation leads to the rupture of the brain-blood barrier and to hippocampal inflammation. As hippocampus mediates the principal cognitive functions, hippocampal inflammation leads to POCD. Orthopedic and cardiac surgery are particularly concerned. Obesity is growing condition in the French population. It is linked to chronic systemic inflammation and altered cognitive functions. We think that obese people may present a susceptibility to POCD because of the pre-operative systemic inflammation.

Conditions

Interventions

TypeNameDescription
BIOLOGICALBlood sampling4 tubes of 7 mL of blood will be collected
BIOLOGICALwhite adipose tissue samplingAt the beginning of the surgery, samples of white adipose tissue from the surgical wound will be collected.

Timeline

Start date
2021-09-21
Primary completion
2024-09-30
Completion
2025-03-30
First posted
2021-05-28
Last updated
2026-03-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04907565. Inclusion in this directory is not an endorsement.